Global Corporate Affairs Archives | Page 6 of 1096 | Be Korea-savvy

Archive by category Global Corporate Affairs

Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026

Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026

CHICAGO, Jan. 07, 2026 (Korea Bizwire) – Amlan® International, a global leader in mineral-based feed additives, will exhibit at the International Production & Processing Expo (IPPE) 2026, taking place January 27–29 at the Georgia World Congress Center in Atlanta, Georgia. Attendees are invited to visit Amlan at booth B6041 to learn how science-backed solutions can help [...]

Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize

Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize

Professor Svetlana Mojsov and Professor Carlos Kenig, among other eminent figures, were selected to win the 48th session of the Prize Riyadh, Saudi Arabia, Jan. 07, 2026 (Korea Bizwire) – Professor Svetlana Mojsov was announced this year’s King Faisal Prize in Medicine laureate for her groundbreaking discoveries that are reshaping how we treat obesity, and [...]

[UPDATE] Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option

[UPDATE] Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option

Modelo launches new Chelada® Limón y Sal Non-Alcoholic – bold and zesty flavor meets moderation just in time for Dry (and Damp) January CHICAGO, Jan. 07, 2026 (Korea Bizwire) – Modelo®, the No. 1 beer brand in the U.S. by sales1, is expanding its portfolio with its first non-alcoholic offering: Modelo Chelada® Limón y Sal Non-Alcoholic. [...]

The CMA Opens the Capital Market to All Categories of Foreign Investors

The CMA Opens the Capital Market to All Categories of Foreign Investors

Riyadh – Saudi Arabia, Jan. 07, 2026 (Korea Bizwire) – The Capital Market Authority (CMA) announces the opening of the capital market to all categories of foreign investors and enabling them to invest directly therein as of 1 February 2026, following the CMA Board’s approval of the regulatory framework allowing non-resident foreign investors to invest [...]

GenAI Company Articul8 AI Raises Series B Led by Adara Ventures, Surpasses $500M Valuation in Under Two Years

GenAI Company Articul8 AI Raises Series B Led by Adara Ventures, Surpasses $500M Valuation in Under Two Years

SANTA CLARA, Calif., Jan. 07, 2026 (Korea Bizwire) – Articul8 AI, Inc. (Articul8), an enterprise generative artificial intelligence (GenAI) software company, today announced it has closed the first tranche of its Series B financing. The oversubscribed round was led by Adara Ventures, with strong participation from NXC Corporation, Aditya Birla Ventures, and other strategic investors. [...]

Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option

Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option

Modelo launches new Chelada® Limón y Sal Non-Alcoholic – bold and zesty flavor meets moderation just in time for Dry (and Damp) January CHICAGO, Jan. 07, 2026 (Korea Bizwire) – Modelo®, the No. 1 beer brand in the U.S. by sales1, is expanding its portfolio with its first non-alcoholic offering: Modelo Chelada® Limón y Sal [...]

BTCS Preannounces Record Revenue for 2025 and Issues Annual Shareholder Letter

BTCS Preannounces Record Revenue for 2025 and Issues Annual Shareholder Letter

Delivered record full-year unaudited revenue of approximately $16 million, a 290% increase Grew total assets by approximately 600% year over year and increased Ethereum holdings to more than 70,500 ETH as of December 31, 2025 WAYNE, Pa., Jan. 07, 2026 (Korea Bizwire) – BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, [...]

Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China

Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China

Curium’s Investigational New Drug (IND) application for 177Lu-PSMA-I&T, a therapeutic agent for patients with metastatic castration-resistant prostate cancer (mCRPC), has been accepted by the Centre for Drug Evaluation (CDE) and it is now under review BOSTON, Jan. 07, 2026 (Korea Bizwire) – Curium Shanghai Pharmaceuticals Co., Ltd. (科锐霖(上海)医药有限公司), has had its Investigational New Drug (IND) application [...]

Bitget Opens TradFi Trading to All Users After Record-Breaking Beta Demand

Bitget Opens TradFi Trading to All Users After Record-Breaking Beta Demand

VICTORIA, Seychelles, Jan. 07, 2026 (Korea Bizwire) – Bitget, the world’s largest Universal Exchange (UEX), has officially opened its TradFi trading suite to all users, following a private beta that drew overwhelming interest and delivered standout trading activity across gold, forex, and global macro assets. The public launch marks a key milestone in Bitget’s evolution into a Universal Exchange [...]

Pluxee Q1 Fiscal 2026 Revenues – Robust start in the 1st quarter delivering on expectations, All Fiscal 2026 financial objectives confirmed

Pluxee Q1 Fiscal 2026 Revenues – Robust start in the 1st quarter delivering on expectations, All Fiscal 2026 financial objectives confirmed

All Fiscal 2026 financial objectives confirmed Q1 Fiscal 2026 Revenues Issy-les-Moulineaux, France – January 7th, 2026 Robust start in the 1st quarter delivering on expectations All Fiscal 2026 financial objectives confirmed Highlights Sustained Employee Benefits business performance in Q1 Fiscal 2026 driven by strong new client acquisition and healthy net retention Total Revenues up +9.0% organically, reaching €308m [...]